Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma

ClinicalTrials.gov ID: NCT00587288

Public ClinicalTrials.gov record NCT00587288. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:56 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Efficacy and Safety Study of Reslizumab in the Treatment of Poorly Controlled Asthma in Subjects With Eosinophilic Airway Inflammation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effectiveness and safety of reslizumab in the treatment of subjects with poorly controlled asthma.

Study identification

NCT ID
NCT00587288
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ception Therapeutics
Industry
Enrollment
106 participants

Conditions and interventions

Conditions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Feb 28, 2010
Completion
Feb 28, 2010
Last update posted
Aug 16, 2016

2008 – 2010

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
23
Facility City State ZIP Site status
Children'S Hospital of Orange County-Pediatric Subspecialty Faculty Orange California 92868
Allergy & Clinical Research Center Centennial Colorado 80112
Asthma & Allergy Associates, P.C. Colorado Springs Colorado 80907
National Jewish Medical & Research Center Denver Colorado 80206
Sneeze, Wheeze & Itch Associates, LLC Normal Illinois 61761
Pulmonary Disease & Critical Care Associates, P.A. Columbia Maryland 21044
Brigham and Women's Hospital Boston Massachusetts 02115
Clinical Research Institute Minneapolis Minnesota 55402
Washington University of School of Medicine St Louis Missouri 63110
The Asthma & Allergy Center Papillion Nebraska 68046
Health Sciences Research at Asthma & Allergy Cortland New York 13045
Wake Forest Univeristy Health Services Winston-Salem North Carolina 27157
David Bernstein Cincinnati Ohio 45229
Toledo Center for Clinical Research Sylvania Ohio 43560
Allergy, Asthma and Clinical Research Center Oklahoma City Oklahoma 73120
Clinical Research Institute of Southern Oregon Medford Oregon 97504
Allergy and Asthma Specialists Blue Bell Pennsylvania 19422
University of Pittsburgh Pittsburgh Pennsylvania 15213
Vanderbilt Asthma Sinus Allergy Program & Research Centers Nashville Tennessee 37203
Virginia Adult & Pediatric Allergy and Asthma Richmond Virginia 23229
Virginia Commonwealth University Richmond Virginia 23298
Asthma, Inc Seatle Washington 98105
Allergy, Asthma and Sinus Center Greenfield Wisconsin 53228
University of Wisconsin-Madison, Allergy/Asthma Clinical Research Unit Madison Wisconsin 53972

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00587288, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 16, 2016 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00587288 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →